J. Essell

发表

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

D. Eisen, J. Essell, E. R. Broun, 2003, Bone Marrow Transplantation.

Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.

K. Sullivan, M. Telen, J. Chute, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and efficacy of polatuzumab vedotin + obinutuzumab for relapsed/refractory non‐Hodgkin lymphomas: A phase IB/II study

I. Flinn, D. Ramies, T. Phillips, 2021, American journal of hematology.

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study.

D. Alberts, C. Moinpour, G. Weiss, 2004, Gynecologic oncology.

Phase II Randomized Double-Blinded Study of Pracinostat in Combination with Azacitidine in Patients with Untreated Higher-Risk Myelodysplastic Syndromes

Farhad, J. Reeves, M. Maris, 2017 .

Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study

J. Delgado, U. Jäger, S. Stilgenbauer, 2020, Clinical Cancer Research.

An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma

J. Burke, J. Essell, Robert Chen, 2018, Clinical lymphoma, myeloma & leukemia.

Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.

J. Reeves, I. Flinn, R. Neuwirth, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Medulloblastoma in an Adult With Late Extraneural Metastases to the Mediastinum

J. Breneman, S. Benzaquen, J. Essell, 2014, Journal of investigative medicine high impact case reports.

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.

P. Riedell, L. Gordon, A. D’Andrea, 2022, The Lancet. Oncology.

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass.

J. Essell, T. J. Martin, V. C. Smith, 1993, Journal of cardiothoracic and vascular anesthesia.

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

J. Weiss, Stephanie J. Lee, O. Schueller, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and Safety of Three Bortezomib-Based Combinations in Elderly, Newly Diagnosed Multiple Myeloma Patients: Results From All Randomized Patients in the Community-Based, Phase 3b UPFRONT Study

J. Reeves, I. Flinn, R. Neuwirth, 2011 .

Polatuzumab Vedotin Combined with Obinutuzumab for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma: Preliminary Safety and Clinical Activity of a Phase Ib/II Study

I. Flinn, T. Phillips, O. Press, 2016 .

Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues.

P. Banks, J. Essell, Paul J. Kurtin, 1991, American journal of clinical pathology.

Abciximab-associated profound thrombocytopenia: therapy with immunoglobulin and platelet transfusion.

D. Kereiakes, J. Essell, C. Abbottsmith, 1996, The American journal of cardiology.

A Randomized, Placebo-Controlled, Phase II Study of Pracinostat in Combination with Azacitidine (AZA) in Patients with Previously Untreated Myelodysplastic Syndrome (MDS)

M. Maris, G. Garcia-Manero, M. Sekeres, 2015 .

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia.

J. Radich, R. Larson, F. Appelbaum, 2020, JCO oncology practice.

Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation

N. Callander, J. Essell, M. Snyder, 1998, Annals of Internal Medicine.

Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients.

N. Callander, J. Thompson, J. Essell, 1992, Bone marrow transplantation.

Oral cavity complications of bone marrow transplantation.

D. Eisen, J. Essell, E. R. Broun, 1997, Seminars in cutaneous medicine and surgery.

Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.

J. Thompson, J. Essell, M. Snyder, 1992, Blood.

SWOG S1203: A Randomized Phase III Study of Standard Cytarabine Plus Daunorubicin (7+3) Therapy Versus Idarubicin with High Dose Cytarabine (IA) with or without Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)

J. Radich, R. Larson, F. Appelbaum, 2016 .

A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

J. Reeves, M. Maris, G. Garcia-Manero, 2020, British journal of haematology.

Phase 2, randomized, double‐blind study of pracinostat in combination with azacitidine in patients with untreated, higher‐risk myelodysplastic syndromes

J. Reeves, M. Maris, H. Kantarjian, 2017, Cancer.

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

J. Burke, J. Reeves, I. Flinn, 2021, Blood advances.

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study.

Michael R Savona, Michael S Weiss, I. Flinn, 2018, The Lancet. Oncology.

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.

N. Callander, N. Flomenberg, J. Essell, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

I. Flinn, J. Hainsworth, L. Hart, 2015, Haematologica.

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

G. Papanicolaou, J. Mehta, J. Panse, 2018, The Lancet.

Phase 3b UPFRONT Study: Safety and Efficacy of Weekly Bortezomib Maintenance Therapy After Bortezomib-Based Induction Regimens In Elderly, Newly Diagnosed Multiple Myeloma Patients

J. Reeves, I. Flinn, R. Neuwirth, 2010 .

Initial Results of KD025-208: A Phase 2a Open-Label Clinical Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease (cGVHD)

Stephanie J. Lee, J. Ryan, O. Schueller, 2018 .

The Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL: Updated Results from the DUO Crossover Extension Study

U. Jaeger, J. Delgado, S. Stilgenbauer, 2018, Blood.

Safety and Efficacy of Polatuzumab Vedotin + Obinutuzumab for Relapsed/Refractory NHL: A Phase 1b/2 Study

I. Flinn, D. Ramies, T. Phillips, 2021 .